Pioneering continuous, reagent-free blood biomarker monitoring to transform critical decision-making in healthcare.
Learn More About Our TechnologyIntermittent biomarker testing often misses crucial changes in a patient's health status. In critical care and high-risk surgical environments, these gaps can hinder early detection of sepsis, shock and anaemia, increasing the risk of delayed critical interventions and worsening patient outcomes.
Chyral's optical sensor solves this by providing continuous, real-time data for haematocrit (Hct), haemoglobin (Hb), arterial oxygen content (SaO2) and lactate directly from standard arterial lines - without chemical reagents.
Our clip-on optical module integrates seamlessly with standard arterial lines, empowering clinicians with actionable data that aligns with established clinical guidelines.
Uninterrupted trend data for comprehensive patient assessment.
Simple add-on to existing arterial lines - plug it in, forget about it & see trend data on your monitor.
Immediate insights for rapid response and timely interventions.
Zero waste and zero additional risk to the patient.
Our novel platform uses Artificial Intelligence (AI) algorithms to interpret light's interaction with biomarkers in blood.
Light's interaction with blood is captured with a miniature optical sensor.
Each biomarker affects the light spectrum in a unique way, providing a spectral fingerprint.
Our core innovation is a novel AI architecture that can interpret this spectral language, translating raw sensor data into biochemical insights.
The output is a list of biomarker levels, easily interpretable and highly informative for clinicians.
Chyral's platform is engineered for growth. We aim to expand from the operating theatre to the intensive care unit and beyond. We envision a future where our optical module is integrated into various existing and future devices. Our mission is to make continuous, intelligent health monitoring accessible and impactful across healthcare.
Discover how Chyral's innovative technology can advance patient care and create value. We are keen to engage with clinicians, healthcare institutions, researchers, and investors.
Melbourne, Australia